Olorundare O E, Simmons S R, Albrecht R M
Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison 53706.
Eur J Cell Biol. 1993 Feb;60(1):131-45.
The movement of platelet membrane glycoproteins was studied by correlative light and electron microscopy. Two distinct classes of movement were seen. In the first type, binding of colloidal gold-labeled ligand or antibody to the fibrinogen receptor (GPIIb/IIIa) triggered a long-range centripetal movement of the receptor-ligand complexes, in the plane of the membrane, on the surfaces of fully spread platelets. This movement was dependent on the presence of the intact cytoplasmic actin cytoskeleton, as evidenced by its inhibition by treatment of the platelets with cytochalasins D and E to disrupt actin filaments. A second surface receptor, the platelet von Willebrand's factor receptor (GPIb), did not undergo this long range, actin-dependent movement in response to antibody binding. However, in a second class of movement, both GPIb and GPIIb/IIIa were translocated on the platelet membrane. Both receptors, GPIb and GPIIb/IIIa, in response to binding of gold-labeled antibody or ligand, accumulated in the channels of the open canalicular system when these were present, and between platelets, under the platelet margins at the sites of platelet-platelet contact. This type of movement occurred only over a much shorter distance than the centripetal movement seen with ligand-bound GPIIb/IIIa and was not affected by the disruption of filamentous actin by the cytochalasins. These results suggest that there are two active mechanisms driving ligand-receptor movement on surface-activated platelets, and that one receptor type may be driven by either mechanism. However, each mechanism predominates at a different stage in the sequence of platelet activation, adherence, and spreading, consistent with differences in function related to receptor-ligand complex formation at the different stages.
通过相关光镜和电镜研究了血小板膜糖蛋白的运动。观察到两种不同类型的运动。在第一种类型中,胶体金标记的配体或抗体与纤维蛋白原受体(GPIIb/IIIa)结合,在完全铺展的血小板表面的膜平面上引发受体-配体复合物的远距离向心运动。这种运动依赖于完整的细胞质肌动蛋白细胞骨架的存在,用细胞松弛素D和E处理血小板以破坏肌动蛋白丝可抑制这种运动,从而证明了这一点。另一种表面受体,即血小板血管性血友病因子受体(GPIb),在抗体结合时不会发生这种远距离的、依赖肌动蛋白的运动。然而,在第二类运动中,GPIb和GPIIb/IIIa都在血小板膜上发生易位。当存在开放小管系统的通道时,GPIb和GPIIb/IIIa这两种受体在金标记抗体或配体结合后,会在这些通道中聚集,并且在血小板之间,在血小板-血小板接触部位的血小板边缘下聚集。这种类型的运动发生的距离比配体结合的GPIIb/IIIa所见的向心运动短得多,并且不受细胞松弛素破坏丝状肌动蛋白的影响。这些结果表明,有两种活性机制驱动表面活化血小板上的配体-受体运动,并且一种受体类型可能由任何一种机制驱动。然而,每种机制在血小板活化、黏附和铺展序列的不同阶段占主导地位,这与不同阶段与受体-配体复合物形成相关的功能差异一致。